Full-Time
Full Stack Developer
Laravel + Vue.js
MicroVentures
51-200 employees
Equity crowdfunding platform for startup investments
No salary listed
Texas, USA
Remote
 Software Engineering (1) |
|---|
- 3–5 years of professional software development experience
- 2+ years of experience with Laravel/PHP
- 2+ years of experience with Vue.js or similar frontend framework (React, Angular)
- Solid understanding of RESTful API design
- Experience with relational databases (MySQL or PostgreSQL)
- Familiarity with Git workflows and version control best practices
- Understanding of testing fundamentals (PHPUnit, Pest, or similar)
- Eagerness to learn and grow technically
- Good communication skills and ability to work collaboratively
- Develop and maintain features using PHP 8.4 and Laravel 12.x
- Build and consume RESTful APIs
- Create responsive UIs using Vue.js 2.x+, and TailwindCSS
- Write clean, tested code following team standards and best practices
- Work with MySQL databases—writing queries, understanding schemas, and running migrations
- Participate in code reviews and incorporate feedback
- Collaborate with product, design, and engineering teammates
- Document your work and contribute to team knowledge base
- Learn and grow with mentorship from senior team members
- Experience with AWS services
- Familiarity with TailwindCSS
- Exposure to Redis or queue systems
- Experience with CI/CD pipelines
- TypeScript experience
MicroVentures runs an equity crowdfunding platform within the fintech space. It lets both accredited and non-accredited investors invest in high-growth startups and private-market opportunities that were once only available to venture funds and institutions. The platform handles the investment process online and charges fees on both sides: investors incur fees based on their investment amount, while companies pay listing fees to run fundraising campaigns. It also provides educational resources to help investors understand equity crowdfunding risks. Compared with competitors, MicroVentures differentiates itself by enabling participation from non-accredited investors and by supporting a dual-fee model on the platform. The company’s goal is to connect a broad range of investors with early-stage opportunities in private markets and to facilitate funding for startups through its online marketplace.
Company Size
51-200
Company Stage
Seed
Total Funding
$1.5M
Headquarters
Austin, Texas
Founded
2009
Simplify's Take
What believers are saying
- Over $550M raised on platform since 2011 across 400+ companies.
- Hybrid model provides Reg CF for non-accredited and Reg D for accredited investors.
- Serves 60,000+ accredited investors including international participants.
What critics are saying
- StartEngine and Wefunder fragment non-accredited investor base within 12-24 months.
- 90% early-stage startup failures damage reputation and deter investors in 6-18 months.
- SEC enforcement suspends operations and broker-dealer status in 18-36 months.
What makes MicroVentures unique
- MicroVentures is the only major equity crowdfunding site registered as FINRA broker-dealer.
- MicroVentures accepts less than 0.5% of startup applicants after rigorous due diligence.
- MicroVentures offers investments starting at $100 for vetted startups since 2009.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at MicroVentures who can refer or advise you
Benefits
Health Insurance
401(k) Retirement Plan
401(k) Company Match
Company Equity
Performance Bonus
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 2%Oakland-based Mighty Buildings, which is on a quest to build homes using 3D printing, robotics and automation, has raised a $22 million extension to its Series B round of funding. The company claims to be able to 3D print structures “two times as quickly with 95% less labor hours and 10-times less waste” than conventional construction. For example, it says it can 3D print a 350-square-foot studio apartment in just 24 hours.
3D Printed Biodegradable Mesh Designed to Deliver Cancer Drugs Directly to Tumor Site With Greater Efficacy, Reduced Side Effects
ICON, in one of the largest seed rounds for Texas start-ups in 2018, announces $9M in funding.
Rochester, MN | February 10, 2023 – Pneumeric Inc., developers of the Capnospot™ - A disposable medical device that allows visual detection of carbon dioxide during treatment of a collapsed lung with needle decompression, has raised nearly $40,000 from 124 investors through its recently launched equity crowdfunding campaign. These funds build on the $1.2 million Pneumeric has
BOSTON, Aug. 15, 2022 /PRNewswire/ -- Remedium Bio, Inc., a biotechnology company developing novel gene therapies, today announced that it has closed more than $2.3M in its expanded seed round financing. Funding from the raise is being used to study Remedium's lead product, a single-injection gene therapy potentially capable of reversing cartilage loss, in a collaboration with Tufts University School of Medicine scientists researching rheumatic disorders. The financing was led by Sherwood Ventures and included participation from, LongevityTech.Fund, Primo Medical Group, Angel Star Ventures, Apis Health Angels, MicroVentures, and Guindy Alumni Angels. Potential to reverse years of age-related cartilage loss Tweet this We believe that any disease can be cured. - Remedium Bio